Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Atrazine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Herbicide |
DME Modulation |
Atrazine up-regulates the expression of DME POR |
[1] |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Pentachlorophenol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01605
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Pentachlorophenol up-regulates the expression of DME POR |
[2] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
Cycloheximide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01268
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Cycloheximide inhibits the drug-metabolizing activity of DME POR |
[3] |
Fipronil |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01302
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Fipronil up-regulates the expression of DME POR |
[4] |
Perfluorodecanoic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01018
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Perfluorodecanoic acid up-regulates the expression of DME POR |
[5] |
Sarin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00779
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Sarin inhibits the drug-metabolizing activity of DME POR |
[6] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the expression of DME POR |
[7] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 inhibits the expression of DME POR |
[8] |
Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Perfluorohexanoic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00920
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Environmental Pollutant |
DME Modulation |
Perfluorohexanoic acid up-regulates the expression of DME POR |
[9] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tris(1,3-dichloro-2-propyl)phosphate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01031
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME POR |
[10] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Dust |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01284
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Dust up-regulates the expression of DME POR |
[11] |
Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Tobacco smoke pollution inhibits the expression of DME POR |
[12] |
Vitallium |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01511
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Vitallium up-regulates the expression of DME POR |
[13] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
6',7'-dihydroxybergamottin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01166
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
6',7'-dihydroxybergamottin inhibits the drug-metabolizing activity of DME POR |
[14] |
Cinnamic aldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01253
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Cinnamic aldehyde up-regulates the expression of DME POR |
[15] |
Hyperforin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01335
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Hyperforin up-regulates the expression of DME POR |
[16] |
Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Jinfukang |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Traditional Medicine |
DME Modulation |
Jinfukang up-regulates the expression of DME POR |
[17] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 13 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen up-regulates the expression of DME POR |
[18] |
Aspirin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00213
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Aspirin inhibits the expression of DME POR |
[19] |
Carbamazepine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00011
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Carbamazepine up-regulates the expression of DME POR |
[20] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME POR |
[7] |
Dimethyl sulfoxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00001
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dimethyl sulfoxide inhibits the drug-metabolizing activity of DME POR |
[21] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME POR |
[22] |
Fenofibrate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00035
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Fenofibrate up-regulates the expression of DME POR |
[23] |
Leflunomide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Leflunomide up-regulates the expression of DME POR |
[24] |
Pyrithione zinc |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00399
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Pyrithione zinc inhibits the expression of DME POR |
[25] |
Rosiglitazone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00380
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Rosiglitazone up-regulates the expression of DME POR |
[26] |
Tretinoin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin induces the drug-metabolizing activity of DME POR |
[27], [28] |
Troglitazone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Troglitazone up-regulates the expression of DME POR |
[29] |
Hemin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01328
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Hemin inhibits the drug-metabolizing activity of DME POR |
[21] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Diethyltoluamide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00582
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Diethyltoluamide up-regulates the expression of DME POR |
[4] |
Epigallocatechin gallate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00613
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Epigallocatechin gallate induces the drug-metabolizing activity of DME POR |
[30] |
Vitamin E |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00547
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Vitamin E up-regulates the expression of DME POR |
[31] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
AM-80 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00622
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2/3 |
DME Modulation |
AM-80 induces the drug-metabolizing activity of DME POR |
[32] |
Bisphenol A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A up-regulates the expression of DME POR |
[33] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Quercetin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Quercetin inhibits the drug-metabolizing activity of DME POR |
[34] |
Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite up-regulates the expression of DME POR |
[35] |
|
|
|
|
|
|